BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borza DB. Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation. Matrix Biol. 2017;57-58:299-310. [PMID: 27609404 DOI: 10.1016/j.matbio.2016.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Collins LE, Troeberg L. Heparan sulfate as a regulator of inflammation and immunity. J Leukoc Biol 2019;105:81-92. [PMID: 30376187 DOI: 10.1002/JLB.3RU0618-246R] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
2 Kikkawa Y, Hashimoto T, Takizawa K, Urae S, Masuda H, Matsunuma M, Yamada Y, Hamada K, Nomizu M, Liapis H, Hisano M, Akioka Y, Miura K, Hattori M, Miner JH, Harita Y. Laminin β2 variants associated with isolated nephropathy that impact matrix regulation. JCI Insight 2021;6:145908. [PMID: 33749661 DOI: 10.1172/jci.insight.145908] [Reference Citation Analysis]
3 Park PW. Introduction to the thematic mini-review series on "Matrix biology in lung health and disease". Matrix Biol 2018;73:1-5. [PMID: 30004014 DOI: 10.1016/j.matbio.2018.07.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
4 Ferreras L, Moles A, Situmorang GR, El Masri R, Wilson IL, Cooke K, Thompson E, Kusche-Gullberg M, Vivès RR, Sheerin NS, Ali S. Heparan sulfate in chronic kidney diseases: Exploring the role of 3-O-sulfation. Biochim Biophys Acta Gen Subj 2019;1863:839-48. [PMID: 30794825 DOI: 10.1016/j.bbagen.2019.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang S, Lu Y, Hong Q, Geng X, Wang X, Zheng W, Song C, Liu C, Fan M, Xi Y, Guo M, Wu D. Protein Array-Based Detection of Proteins in Kidney Tissues from Patients with Membranous Nephropathy. Biomed Res Int 2017;2017:7843584. [PMID: 28337458 DOI: 10.1155/2017/7843584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Hull EE, Montgomery MR, Leyva KJ. Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers. Int J Mol Sci 2017;18:E1361. [PMID: 28672878 DOI: 10.3390/ijms18071361] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
7 Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol 2019;15:346-66. [PMID: 30858582 DOI: 10.1038/s41581-019-0129-4] [Cited by in Crossref: 287] [Cited by in F6Publishing: 263] [Article Influence: 143.5] [Reference Citation Analysis]
8 Lin CJ, Hu ZG, Yuan GD, Lei B, He SQ. Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis. World J Hepatol 2018; 10(10): 662-669 [PMID: 30386459 DOI: 10.4254/wjh.v10.i10.662] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Djudjaj S, Boor P. Cellular and molecular mechanisms of kidney fibrosis. Mol Aspects Med 2019;65:16-36. [PMID: 29909119 DOI: 10.1016/j.mam.2018.06.002] [Cited by in Crossref: 95] [Cited by in F6Publishing: 92] [Article Influence: 23.8] [Reference Citation Analysis]
10 Ravindran A, Casal Moura M, Fervenza FC, Nasr SH, Alexander MP, Fidler ME, Herrera Hernandez LP, Zhang P, Grande JP, Cornell LD, Gross LA, Negron V, Jenson GE, Madden BJ, Charlesworth MC, Sethi S. In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes. J Am Soc Nephrol 2021;32:695-706. [PMID: 33478971 DOI: 10.1681/ASN.2020081181] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
11 Falcone S, Nicol T, Blease A, Randles MJ, Angus E, Page A, Tam FWK, Pusey CD, Lennon R, Potter PK. A novel model of nephrotic syndrome results from a point mutation in Lama5 and is modified by genetic background. Kidney Int 2021:S0085-2538(21)01058-9. [PMID: 34774562 DOI: 10.1016/j.kint.2021.10.031] [Reference Citation Analysis]
12 Bülow RD, Boor P. Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold. J Histochem Cytochem 2019;67:643-61. [PMID: 31116062 DOI: 10.1369/0022155419849388] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 19.3] [Reference Citation Analysis]
13 Mannes M, Dopler A, Huber-Lang M, Schmidt CQ. Tuning the Functionality by Splicing: Factor H and Its Alternative Splice Variant FHL-1 Share a Gene but Not All Functions. Front Immunol 2020;11:596415. [PMID: 33178228 DOI: 10.3389/fimmu.2020.596415] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
14 Naylor RW, Morais MRPT, Lennon R. Complexities of the glomerular basement membrane. Nat Rev Nephrol 2021;17:112-27. [PMID: 32839582 DOI: 10.1038/s41581-020-0329-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
15 Desideri S, Onions KL, Baker SL, Gamez M, El Hegni E Hussien H, Russell A, Satchell SC, Foster RR. Endothelial glycocalyx restoration by growth factors in diabetic nephropathy. Biorheology 2019;56:163-79. [PMID: 31156139 DOI: 10.3233/BIR-180199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
16 Chan GC, Eng DG, Miner JH, Alpers CE, Hudkins K, Chang A, Pippin JW, Shankland SJ. Differential expression of parietal epithelial cell and podocyte extracellular matrix proteins in focal segmental glomerulosclerosis and diabetic nephropathy. Am J Physiol Renal Physiol 2019;317:F1680-94. [PMID: 31630546 DOI: 10.1152/ajprenal.00266.2019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
17 Piras R, Breno M, Valoti E, Alberti M, Iatropoulos P, Mele C, Bresin E, Donadelli R, Cuccarolo P, Smith RJH, Benigni A, Remuzzi G, Noris M. CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis. Front Genet 2021;12:670727. [PMID: 34211499 DOI: 10.3389/fgene.2021.670727] [Reference Citation Analysis]
18 Perry G, Xiao W, Welsh GI, Perriman AW, Lennon R. Engineered basement membranes: from in vivo considerations to cell-based assays. Integr Biol 2018;10:680-95. [DOI: 10.1039/c8ib00138c] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
19 Wang C, Wang Z, Zhang W. The potential role of complement alternative pathway activation in hypertensive renal damage. Exp Biol Med (Maywood) 2022;:15353702221091986. [PMID: 35473318 DOI: 10.1177/15353702221091986] [Reference Citation Analysis]
20 Liu P, Xie X, Jin J. Isotopic Nitrogen-15 Labeling of Mice Identified Long-lived Proteins of the Renal Basement Membranes. Sci Rep 2020;10:5317. [PMID: 32210336 DOI: 10.1038/s41598-020-62348-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
21 Luo W, Olaru F, Miner JH, Beck LH Jr, van der Vlag J, Thurman JM, Borza DB. Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy. Front Immunol 2018;9:1433. [PMID: 29988342 DOI: 10.3389/fimmu.2018.01433] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]